Among bioassays for evaluating various impacts of chemicals on humans and e
cosystems, those based on cultured mammalian-cells can best predict acute l
ethal toxicity to humans. We expect them to be employed in the future in en
vironmental risk management alongside mutagenicity tests and endocrine-disr
upting activity tests. We recently developed a disposable bioassay device t
hat immobilizes human hepatocarcinoma cells in a small micropipette tip. Th
is enables very quick (within 2 h) evaluation of acute lethal toxicity to h
umans. For bioassay-based environmental management, 2 promising approaches
have been demonstrated by the US-EPA: toxicity identification evaluation (T
IE) and toxicity reduction evaluation (TRE). The Japanese Ministry of Envir
onment has been supporting a multi-center validation project, aimed at asse
mbling a bioassay database. To make full use of these resources, we present
a numerical model that describes contribution of individual chemical to ob
served toxicity. This will allow the selection of the most effective counte
rmeasure to reduce the toxicity. Bioassay-based environmental risk manageme
nt works retrospectively, whereas impact assessment using substance flow mo
dels and toxicity databases works prospective. We expect that these 2 appro
aches will exchange information, act complementarily, and work effectively
in keeping our environment healthy in the 21st century.